We also found that miR-4739 mediated m1A methylation by inhibiting TRMT61A. These findings provide a new perspective on the spatial interplay between RNA epigenetic modifications and immune cell subsets within the tumor microenvironment, offering novel molecular targets for HCC immunotherapy. The gene discussed is TRMT61A; the disease is hepatocellular carcinoma.